Revenue | ₹73.25Cr |
Net Profits | ₹0.06Cr |
Net Profit Margins | 0.08% |
Mangalam Drugs and Organics Ltd’s revenue fell -28.38% since last year same period to ₹73.25Cr in the Q4 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -17.56% fall in its revenue since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit fell -98.3% since last year same period to ₹0.06Cr in the Q4 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -95.35% fall in its net profits since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit margin fell -97.63% since last year same period to 0.08% in the Q4 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -94.36% fall in its net profit margins since last 3-months.
The revenue for Mangalam Drugs and Organics Ltd in the Q4 results 2024 was ₹73.25Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q4 results 2024 was ₹0.06Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q4 results 2024 was 0.08%.
The revenue for Mangalam Drugs and Organics Ltd in the Q4 results 2023 was ₹102.28Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q4 results 2023 was ₹3.53Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q4 results 2023 was 3.45%.